Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12403165 | Oncolytic immunotherapy by tumor micro-environment remodeling | Mingrui ZHANG, Daniel J. Byrd | 2025-09-02 |
| 12318419 | Platform oncolytic vector for systemic delivery | Daniel J. Byrd, Mingrui ZHANG | 2025-06-03 |
| 12246049 | Oncolytic viruses targeting STAT3 | Daniel J. Byrd | 2025-03-11 |
| 12226440 | Platform oncolytic vector for systemic delivery | Daniel J. Byrd, Mingrui ZHANG | 2025-02-18 |
| 12150969 | Synthetically enveloped virus | Song Li | 2024-11-26 |
| 12036257 | Platform oncolytic vector for systemic delivery | Daniel J. Byrd, Mingrui ZHANG | 2024-07-16 |
| 12016893 | Oncolytic viruses for modified MHC expression | Mingrui ZHANG | 2024-06-25 |
| 11963990 | Oncolytic viruses for modified MHC expression | Mingrui ZHANG | 2024-04-23 |
| 11786569 | Expression of metabolic modulators in tumor microenvironment to improve tumor therapy | Greg M. Delgoffe, Dayana Rivadeneira, Padmavathi Sampath | 2023-10-17 |
| 11478518 | Immuno-oncolytic therapies | — | 2022-10-25 |
| 11253559 | Oncolytic viruses targeting STAT3 | Daniel J. Byrd | 2022-02-22 |
| 11065286 | High mobility group box I mutant | — | 2021-07-20 |
| 10064893 | Immune effector cells pre-infected with oncolytic virus | Christopher H. Contag | 2018-09-04 |
| 9101658 | Immune effector cells pre-infected with oncolytic virus | Christopher H. Contag | 2015-08-11 |
| 7687474 | Nitroreductase enzymes | A. C. Matin, Yoram Barak, Susan Lynch, David Francis Ackerley, Christopher H. Contag +1 more | 2010-03-30 |